64 Cu PET imaging. Bioconjugation to antibody, radiolabeling and preclinical application in xenografted colorectal cancer (original ) (raw )Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice
Cyrille Alliot
Nuclear Medicine and Biology, 2014
View PDFchevron_right
Imaging cancer using PET — the effect of the bifunctional chelator on the biodistribution of a 64Cu-labeled antibody
Frederic Fahey , Erin Snay
Nuclear Medicine and Biology, 2011
View PDFchevron_right
Cyclam-Based Chelators Bearing Phosphonated Pyridine Pendants for 64 Cu-PET Imaging: Synthesis, Physicochemical Studies, Radiolabeling, and Bioimaging
Loïc Charbonnière
Inorganic Chemistry, 2021
View PDFchevron_right
Copper-64-labeled antibodies for PET imaging
Sally Schwarz
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992
View PDFchevron_right
A Versatile Bifunctional Chelate for Radiolabeling Humanized Anti-CEA Antibody with In-111 and Cu-64 at Either Thiol or Amino Groups: PET Imaging Of CEA-Positive Tumors with Whole Antibodies
Paul Yazaki
Bioconjugate Chemistry, 2008
View PDFchevron_right
Cyclam te1pa for64Cu PET imaging. Bioconjugation to antibody, radiolabeling and preclinical application in xenografted colorectal cancer
Michel Chérel
RSC Adv.
View PDFchevron_right
Comparison of bifunctional chelates for 64Cu antibody imaging
Donald Yapp
European Journal of Nuclear Medicine and Molecular Imaging, 2010
View PDFchevron_right
New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging
Dexing Zeng
Inorganic chemistry, 2016
View PDFchevron_right
PET/CT Based In Vivo Evaluation of Cu-64 Labelled Nanodiscs in Tumor Bearing Mice
Pie Huda
2015
View PDFchevron_right
Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety
Jacques Barbet
Cancers
View PDFchevron_right
Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals
Donald Yapp
Nuclear Medicine and Biology, 2008
View PDFchevron_right
Preparation, quality control and biodistribution studies of ( 61 Cu)-oxinate for PET tumor imaging
Hassan Yousefnia
Nukleonika, 2009
View PDFchevron_right
Cyclam-Based Chelators Bearing Phosphonated Pyridine Pendants for 64Cu-PET Imaging : Synthesis, Physico-Chemical Studies, Radiolabeling and Bioimaging
Loïc Charbonnière
2020
View PDFchevron_right
Synthesis and Preclinical Studies of [61 Cu]-N-(2-Hydroxyacetophenone) Glycinate As a Possible PET Radiopharmaceutical
hassan zandi
Sci Pharm, 2008
View PDFchevron_right
First-in-Human Evaluation of Safety and Dosimetry of 64 Cu-LLP2A for PET Imaging
Anchal Ghai
The Journal of Nuclear Medicine, 2022
View PDFchevron_right
AAZTA: An Ideal Chelating Agent for the Development of (44) Sc PET Imaging Agents
Anikó Fekete
Angewandte Chemie (International ed. in English), 2017
View PDFchevron_right
Synthesis, characterisation and evaluation of a novel copper-64 complex with selective uptake in EMT-6 cells under hypoxic conditions
Fawaz A Saad
Dalton Transaction, 2013
View PDFchevron_right
PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate
Roger Price
Dalton Transactions, 2014
View PDFchevron_right
PET/CT Based In Vivo Evaluation of 64Cu Labelled Nanodiscs in Tumor Bearing Mice
Lise Arleth , Pie Huda
PLOS ONE, 2015
View PDFchevron_right
Evaluation of134Ce/134La as a PET Imaging Theranostic Pair for225Ac α-Radiotherapeutics
Cyril Fong
Journal of Nuclear Medicine
View PDFchevron_right
Preclinical studies of [61 Cu] ATSM as a PET radiopharmaceutical for fibrosarcoma imaging
Mehdi Akhlaghi
Acta pharmaceutica, 2009
View PDFchevron_right
Comparison of DOTA and NODAGA as chelators for 64Cu-labeled immunoconjugates
Kenneth Pinkston
Nuclear Medicine and Biology, 2015
View PDFchevron_right
RESEARCH ARTICLE PET/CT Based In Vivo Evaluation of 64Cu Labelled Nanodiscs in Tumor Bearing Mice
Pie Huda
2016
View PDFchevron_right
Evaluation of 111In-labeled macrocyclic chelator-amino acid derivatives for cancer imaging
Yunsang Lee
Nuclear Medicine and Biology, 2012
View PDFchevron_right
Preclinical evaluation of a CXCR4-specific 68Ga-labelled TN14003 derivative for cancer PET imaging
Federica Pisaneschi
Bioorganic & Medicinal Chemistry, 2014
View PDFchevron_right
Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy
Carolyn Henry
Cancer Biology & Therapy, 2011
View PDFchevron_right
Improved PET Imaging of uPAR Expression Using new 64Cu-labeled Cross-Bridged Peptide Ligands: Comparative in vitro and in vivo Studies
Jacob Madsen
Theranostics, 2013
View PDFchevron_right
PET of Somatostatin Receptor–Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference
Helmut Maecke
Journal of Nuclear Medicine, 2011
View PDFchevron_right
Strategies for Optimized Radiolabeling of Nanoparticles for in vivo PET Imaging
Guorong Sun
Advanced Materials, 2007
View PDFchevron_right
Site-Specific Conjugation of Monodispersed DOTA-PEGn to a Thiolated Diabody Reveals the Effect of Increasing PEG Size on Kidney Clearance and Tumor Uptake with Improved 64-Copper PET Imaging
David Colcher
Bioconjugate Chemistry, 2011
View PDFchevron_right
Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64 Cu-SarAr immunoconjugates
Suzanne Smith
Proceedings of the National Academy of Sciences, 2007
View PDFchevron_right